<?xml version="1.0" encoding="UTF-8"?>
<p>The unique signaling pathways of PASCs were the HIF-1 signaling pathway, p53 signaling pathway, cell cycle, and apoptosis. Previous studies indicated that the HIF-1 signaling pathway is associated with multiple tumor progressions (
 <xref rid="B51" ref-type="bibr">Zhong et al., 1999</xref>; 
 <xref rid="B45" ref-type="bibr">Talks et al., 2000</xref>), and dysregulation of cell cycle components may also lead to tumorigenesis, which results in cell proliferation by p53 or other signaling pathways (
 <xref rid="B10" ref-type="bibr">Champeris Tsaniras et al., 2014</xref>). Inhibition of apoptosis can also lead to a variety of cancers, inflammatory diseases, and viral infections (
 <xref rid="B25" ref-type="bibr">Kaczanowski, 2016</xref>). Therefore, the increased risk of cancer in obese or overweight patients may be related to PASCs.
</p>
